The company aims to enroll 30,000 adults in the clinical trial, which is designed to test whether the vaccine works to prevent COVID-19. The trial will also look at the vaccine's safety.
Participants will either receive the vaccine or a placebo. They will be tracked for two years to see whether they get COVID-19 or have any adverse reactions to the vaccine.In May, Moderna releasedfrom its phase 1 clinical trial, which involved 45 participants. Phase 1 trials are meant to test a new drug's safety, not its effectiveness.
The company said that results from eight of those participants showed they had developed antibodies key to fighting the virus, though it did not publish the full trial results.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna expects to start late-stage COVID-19 vaccine trial on July 27Moderna Inc said on Tuesday it plans to start a late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at clinicaltrials.gov. At this point in the constant pump train, would they even tell us about severe side effects? When Trump said by the end of the year everybody laughed at him stop hating and start hoping Why does it look like Tesco own brand?
Source: Reuters - 🏆 2. / 97 Read more »
Three generations of Bollywood's Bachchan family hit by COVID-19Revered Bollywood actor Amitabh Bachchan's daughter-in-law and granddaughter have joined him and his son in testing positive for COVID-19, the family said on Sunday, in one of the highest-profile cases of the pandemic sweeping India. Tell them to drink my drink and it will help them st daniel 😂😂😂 Damn what this statue gonna do with coronavirus 🙆♂️
Source: Reuters - 🏆 2. / 97 Read more »